Note · Research
Previewing ESC Congress 2026: Key Cardiovascular Medical Device Innovators
The European Society of Cardiology (ESC) Congress 2026 is set to convene in Munich, Germany, from August 28 to 31, 2026. This global gathering serves as a critical platform for professionals and industry partners to explore scientific developments in cardiovascular health, with a particular emphasis on the integration of artificial intelligence in cardiology. For B2B medical device manufacturers, the event offers a prime opportunity to present their latest product lines and engage with a global audience of specialists.
As the industry looks towards 2026, several prominent companies in the cardiovascular medical device sector are expected to be key participants, showcasing their contributions to this evolving field. These firms, known for their extensive portfolios, play a significant role in the B2B landscape by developing and supplying advanced technologies.
Leading Cardiovascular Medical Device Manufacturers at ESC Congress 2026
The cardiovascular medical device sector is dynamic, with companies continually innovating their product lines. The table below provides an overview of some of the major players in this space, detailing their headquarters, founding year, and key product line categories as publicly disclosed.
| Company | Headquarters | Founded | Key Product Lines |
|---|---|---|---|
| Medtronic | Ireland (legal/executive), U.S. (operational) | 1949 | Cardiac Rhythm, Heart Failure, Structural Heart and Aortic, Coronary and Peripheral, Interventional Cardiology, Cardiac Surgery, Vascular Surgery |
| Boston Scientific | Marlborough, Massachusetts, U.S. | 1979 | Interventional Cardiology, Peripheral Interventions, Electrophysiology, Cardiac Rhythm Management, Remote Patient Management, Cardiac Monitoring, Intravascular Imaging, Vessel Preparation, Coronary Drug-Eluting Therapies, Pulsed Field Ablation |
| Abbott Laboratories (Abbott Vascular) | Abbott Park, Illinois, U.S. | 1888 | Insertable Cardiac Monitors, Heart Valve Repair and Replacement, Ablation Catheters, Pacemakers, Stents, Heart Pumps, Atherectomy Systems, Intravascular Imaging Platforms |
| Edwards Lifesciences | Irvine, California, U.S. | 1958 | Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Valve Technologies, Implantable Heart Failure Management |
| Philips Healthcare | Amsterdam, Netherlands | 1891 (Royal Philips) | Cardiovascular Ultrasound Systems, Image-Guided Therapy Systems, Interventional Devices (Intravascular Imaging Catheters, Specialty Balloons, Atherectomy Devices, Pressure Guide Wires, Lead Management Devices) |
| Siemens Healthineers | Erlangen, Germany | 2017 (as separate entity) | Cardiac Systems, Cardiac Assays, Interventional Cardiology Imaging Systems, CT Cardiovascular Imaging, Cardiovascular MRI, Cardiac Point-of-Care Solutions |
Company Profiles: Global Cardiovascular Device Innovators
Each of these companies contributes to the global medical device market through their specialized B2B product offerings, supporting healthcare providers with a range of technologies.
Medtronic
Medtronic maintains its legal and executive headquarters in Ireland, with significant operational headquarters in Minneapolis, Minnesota, U.S. Founded in 1949, the company has developed an extensive portfolio of cardiovascular product lines. These include solutions for cardiac rhythm management, heart failure, structural heart and aortic conditions, and coronary and peripheral interventions. Medtronic also offers distinct product lines for interventional cardiology, cardiac surgery, and vascular surgery, with ongoing developments in areas like pulsed field ablation technologies.
Boston Scientific
Headquartered in Marlborough, Massachusetts, U.S., Boston Scientific was founded on June 29, 1979. The company's cardiovascular segment is comprehensive, featuring product lines in interventional cardiology, peripheral interventions, and electrophysiology. Its offerings span cardiac rhythm management devices, remote patient management systems, and cardiac monitoring systems. Additionally, Boston Scientific provides intravascular imaging, vessel preparation technologies, coronary drug-eluting therapies, and pulsed field ablation systems.
Abbott Laboratories (Abbott Vascular)
Abbott Laboratories, including its Abbott Vascular division, is headquartered in Abbott Park, Illinois, U.S. The company was founded in 1888 as the Abbott Alkaloidal Company. Its cardiovascular product offerings encompass insertable cardiac monitors, heart valve repair and replacement systems, and ablation catheters. Abbott also provides pacemakers, stents, heart pumps, atherectomy systems, and advanced intravascular imaging platforms.
Edwards Lifesciences
Edwards Lifesciences is based in Irvine, California, U.S., and was founded in 1958. The company specializes in structural heart innovation, with core product lines in transcatheter aortic valve replacement, transcatheter mitral and tricuspid therapies, and surgical valve technologies. Edwards Lifesciences is also actively developing implantable heart failure management solutions, reflecting its focus on advanced heart care.
Philips Healthcare
As part of Royal Philips, Philips Healthcare's headquarters are in Amsterdam, Netherlands. Royal Philips was founded in 1891. Philips Healthcare's cardiovascular portfolio includes advanced cardiovascular ultrasound systems and image-guided therapy systems. Their interventional devices product line features intravascular imaging catheters, specialty balloons, atherectomy devices, pressure guide wires, and lead management devices, catering to various procedural needs.
Siemens Healthineers
Siemens Healthineers is headquartered in Erlangen, Germany. While Siemens AG was founded in 1847, Siemens Healthineers was established as a separate entity in 2017. The company’s cardiology portfolio includes cardiac systems, cardiac assays, and interventional cardiology imaging systems. They also provide CT cardiovascular imaging solutions, cardiovascular MRI, and cardiac point-of-care solutions, contributing to a broad spectrum of cardiovascular diagnostics and interventions.
Industry Landscape: Advancements and B2B Focus
The medical device industry, particularly in the cardiovascular segment, is characterized by continuous technological advancement. Events like ESC Congress 2026 highlight this evolution, especially with the growing emphasis on integrating artificial intelligence into cardiology. For B2B manufacturers, this translates into developing sophisticated systems and components that support more precise diagnostics, interventional procedures, and patient management. Companies in this sector focus on delivering reliable, high-performance equipment and solutions that meet the evolving demands of healthcare providers globally, driving innovation from a manufacturing and supply perspective.
Looking Ahead: Engage with Protonmeds
The ESC Congress 2026 promises to be a pivotal event for the cardiovascular medical device community, showcasing the latest innovations from leading manufacturers. As protonmeds continues to track the global medical device landscape, we are keen to hear from our readers. Which medical device product category should protonmeds profile next?